Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
True Light Capital is a Singapore-based investment management firm and an independent subsidiary of Temasek Holdings. Established in 2021, the firm specializes in private equity and venture capital investments with a primary geographic focus on the Greater China region. True Light Capital is a significant player in the life sciences and healthcare investment landscape, backing innovative companies in sectors such as biotechnology, medical devices, and digital health. The firm manages the True Light Fund I and leverages Temasek's extensive global network and institutional expertise to drive value for its portfolio companies. Its investment strategy encompasses various stages of company growth, from venture-backed startups to late-stage private equity opportunities. By providing long-term capital and strategic support, True Light Capital aims to foster the growth of market leaders in high-impact industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on True Light Private Equity.